DexCom Inc.

Despite limited economic data and earnings today, momentum builds, especially in some speculative stocks.

Investors welcomed lower interest rates with a resounding rally, which saw all U.S. stock benchmarks notch record closes.

AI was huge in 2024. The underperformers list reflects challenges in the other sectors.

Here are the stocks making the biggest market moves midday.

Here are the stocks making the biggest market moves midday.

Here are the stocks making the biggest market moves midday.

Here are the stocks making the biggest market moves today.

Here are the stocks making the biggest market moves today.

Here are the stocks making the biggest market moves today.

Tech stocks crashed amid AI doubt and recession fear.

Stocks rallied after an encouraging PCE inflation print, but not every company is a winner today.

Intuitive Surgical skyrocketed today, but it's not the only healthcare stock worth owning.

Apple is developing its watch as a health monitoring device to include noninvasive monitoring of glucose levels.

Which stocks should you consider with the S&P 500 having lost 8.6% so far this year, even after its two-day rebound?

These are companies that can raise prices without fear of losing customers as a result. The chosen companies have high margins.

With some parts of the stock market down sharply, Jim Cramer says investors need to take advantage of the declines and find something to buy.

Jim Cramer says he thinks he knows why the markets are rallying despite rising inflation.

Jim Cramer says it sometimes pays to look past the flash and seek out the stock of solid, dependable companies we all need.

Jim Cramer looks at the aftermath of the Federal Reserve call, and says he sees opportunity in select tech stocks, homebuilders and fintech.

Let's assess the damage here.

The charts of the medical device maker are weakening. Here's what traders need to know.

As the market sees 700 new 12-month highs and Nvidia and Alphabet attract cash, I've got these names on my radar.

As we're watching a surprise reversal move in the super stocks, I've got my eyes on three names.

DXCM had a much longer sideways period than anticipated but the uptrend has resumed.

The shares gapped higher Friday to refresh the uptrend.

Traders who are long the stock of the medical device company should continue to hold their shares.

Here's what traders should do now.

Let's look at the charts and indicators.

Should investors fade out, do a double-take or be at the ready for a buy? Let's check the charts following a fundamental upgrade.

The stock of the maker of glucose monitoring systems may be seeking a bottom but it isn't clear whether it has gotten there yet.

DXCM is now trading above the rising 50-day moving average line and the rising 200-day line.

The great thing about Google? Unlike IBM? It isn't trumpeting anything. It's just talking about algorithms, let the eyes glaze over.

Let's review the charts and indicators.

Who knew high finance was so easy? And why the heck was I working so hard? Fundamental analysis is so 1980s.

Breadth is looking good -- unless you measure it against this index, and that's why I'm now watching closely.

Investors continue to be more aggressive sellers of DXCM.

A 'careful' approach is in order for traders.

Right now, the market is furiously trying to price in a Blue Wave, and the health care sector is getting clobbered. But here's how I think things play out.

The investment firm's analysts share their views about the precious metal.

UnitedHealth, still reeling from the murder of one of its top executives, is reportedly facing a Department of Justice investigation.

The federal agency has opted to make a drastic decision during a critical time of the year.